Elexacaftor/tezacaftor/ivacaftor Treatment Reduces Airway Inflammation in Cystic Fibrosis

Autor:	Richard C. De Vuyst, Erin Bennard, Charissa Kam, Cameron McKinzie, Charles Esther
Rok vydání:	2022
DOI:	10.22541/au.167170864.42960149/v1
Popis:	ETI treatment reduces inflammatory markers and positive bacterial cultures on BAL in PwCF. These findings suggest that ETI has a greater impact on chronic infection and inflammation than ivacaftor alone. However, airway inflammation persists in a fraction of treated individuals, indicating an ongoing need to optimize other treatments in a subset of patients.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e7c8b0d2683f94d99195b4f3067c3743 https://doi.org/10.22541/au.167170864.42960149/v1 Zobrazit plný text záznamu